Skip to content

Use of suPAR Algorithm for the ED Decision Making

Use of Algorithm for Safer and More Efficient Decision Making in the ED

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04402281
Acronym
EDsuPAR
Enrollment
1800
Registered
2020-05-26
Start date
2020-05-11
Completion date
2021-06-01
Last updated
2022-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness

Keywords

ED, Critical illness, Decision making, POC test, suPAR

Brief summary

Will the use of a clinical decision algorithm in the ED improve discharge or admission decisions.

Detailed description

Background Crowding and readmissions are common challenges in Emergency departments across Europe. The decision whether to admit or discharge the patient is challenging and is often based on clinical signs and symptoms e.g. blood pressure, pulse, respiratory rate, oxygen saturation and temperature. But some patients are unnecessarily admitted and may have been better off if sent home. Other patients may be discharged without - and one out of five patients are readmitted within a month raising the question whether the patient should have been admitted at first presentation in the ED. suPAR is a strong prognostic biomarker measured routinely in acute medical patients in some emergency department (ED) settings.suPAR is a broadly applicable biomarker of risk, and it has been developed an algorithm for simple interpretation of suPAR in clinical decisions for the study. Objective To evaluate the use of a clinical decision algorithm in the ED with the aim of improving discharge or admission decisions.

Interventions

DIAGNOSTIC_TESTsuPAR algoritm

All medical patients attending to the ED and who will have blood drawn for routine examination will be part of the study. In patients with low suPAR (green group, suPAR below 3 ng/ml) and in patients with high suPAR (red group, suPAR \> 6 ng/mL) the Intervention will be carried out

Sponsors

University of Copenhagen
CollaboratorOTHER
Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 104 Years
Healthy volunteers
Yes

Inclusion criteria

* All patients above 18 years * who are having blood taken for biochemical analysis when attending the ED

Exclusion criteria

* Acute medical patients that do not have blood drawn for routine biochemical testing. * Pregnant * Under 18 years old * Terminally ill patients.

Design outcomes

Primary

MeasureTime frameDescription
Discharges30 daysNumber of discharges from the ED within 24 hours

Secondary

MeasureTime frameDescription
Admissions30 daysNumber of admissions to hospital
Length of stay30 daysLength of stay during admission
Readmissions1,7 and 30 daysNumber of readmissions
Mortality30 daysNumber of Mortality

Other

MeasureTime frameDescription
Economical savings30 daysAmount of money

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026